<DOC>
	<DOCNO>NCT02749396</DOCNO>
	<brief_summary>Multiple Sclerosis ( MS ) common chronic neurologic disability young adult female childbearing age . Little evidence available regard association exposure IFN-beta ( β ) product adverse pregnancy outcome . Therefore four marketing holder IFN-β conduct European-wide IFN-β pregnancy registry . Additionally , Committee Medicinal Products Human Use ( CHMP ) request study enable identification pregnancy outcomes MS population unexposed IFN-β product comparison ongoing European IFN-β Pregnancy Registry .</brief_summary>
	<brief_title>EPID Multiple Sclerosis Pregnancy Study</brief_title>
	<detailed_description>Information obtain Drugs Pregnancy Project database ( DPP - FIN ) Medical Birth Register ( MBR - SWE , NOR ) . The Finnish DPP Norwegian MBR include information stillbirths foetuses birth weight least 500 g gestational age least 22+0 Gestational Week ( GW ) . The Swedish MBR include data stillbirth 28 GW The estimated number pregnancy MS patient needed 1671 , encompass data : ) FIN : 1 January 1996 - 31 December 2014 ; ii ) SWE : 1 July 2005 - 31 December 2014 ; iii ) NOR : 1 January 2004 - 31 December 2014 .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1a</mesh_term>
	<mesh_term>Interferon beta-1b</mesh_term>
	<criteria>Women pregnancy record outcome consisting induced abortion , spontaneous abortion , ectopic pregnancy , birth study period FIN , SWE NOR event document relevant database .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>